Cadonilimab in combined with gemcitabine and cisplatin in advanced biliary tract cancer (BicureX): A phase II, single-arm clinical trial.

被引：0
|
作者：
Ma, Ji
Wang, Tao
Chen, Yidi
Yang, Yi
Qiu, Yiwen
Shen, Shu
Yi, Cheng
Wang, Wentao
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16158
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II trial of gemcitabine plus cisplatin (GP) in patients with inoperable biliary tract cancer (BTC).
    Park, JO
    Kang, WK
    Kim, TY
    Lee, MA
    Ahn, MJ
    Kim, HK
    Lee, NS
    Lim, HY
    Park, BJ
    Kim, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 341S - 341S
  • [32] Sintilimab plus gemcitabine and cisplatin as a first-line treatment for patients with advanced biliary tract cancer: A biomolecular exploratory, phase II clinical trial
    Yuan, Zhen-Gang
    Zeng, Tian-Mei
    Yang, Guang
    Lou, Cheng
    Wei, Wei
    Tao, Chen-Jie
    Chen, Xi-Yun
    Han, Qin
    Cheng, Zhuo
    Shang, Pei-Pei
    Dong, Yu-Long
    Xu, He-Ming
    Guo, Lie-Ping
    Chen, Dong-Sheng
    Song, Yunjie
    Qi, Chuang
    Deng, Wanglong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
    Penz, M
    Kornek, GV
    Raderer, M
    Ulrich-Pur, H
    Fiebiger, W
    Lenauer, A
    Depisch, D
    Krauss, G
    Schneeweiss, B
    Scheithauer, W
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 183 - 186
  • [34] Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma
    Kang, Myoung Joo
    Lee, Jae-Lyun
    Kim, Tae Won
    Lee, Sung Sook
    Ahn, Shin
    Park, Do Hyun
    Lee, Sang Soo
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    ACTA ONCOLOGICA, 2012, 51 (07) : 860 - 866
  • [35] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open-label, single-arm, phase Ib clinical trial.
    Liu, Zhigang
    Huang, Xiaotao
    Liang, Jun
    Zhong, Guihua
    Liu, Ye
    Liang, Lizhong
    Hong, Haiyu
    Feng, Weineng
    Yang, Shuang
    Zhang, Yaqin
    Peng, Yingpeng
    Liu, Qiandan
    Zhou, Yuling
    Zhang, Zhaoyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
    Kanai, Masashi
    Hatano, Etsuro
    Kobayashi, Syogo
    Fujiwara, Yutaka
    Sakai, Daisuke
    Kodama, Yuzo
    Ajiki, Tetsuo
    Nagano, Hiroaki
    Ioka, Tatsuya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1181 - 1188
  • [37] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
    Masashi Kanai
    Etsuro Hatano
    Syogo Kobayashi
    Yutaka Fujiwara
    Daisuke Sakai
    Yuzo Kodama
    Tetsuo Ajiki
    Hiroaki Nagano
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1181 - 1188
  • [38] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
    Kobayashi, Shogo
    Kanai, Masashi
    Hatano, Etsuro
    Fujiwara, Yutaka
    Sakai, Daisuke
    Kodama, Yuzo
    Ajiki, Tetsuo
    Nagano, Hiroaki
    Ioka, Tatsuya
    HEPATOLOGY, 2012, 56 : 470A - 471A
  • [39] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
    Qiao, Qian
    Han, Chun
    Ye, Sisi
    Li, Juan
    Shao, Guoliang
    Bai, Yuxian
    Xu, Aibing
    Sun, Meili
    Wang, Wei
    Wu, Jian
    Huang, Ming
    Song, Lijie
    Huang, Luke
    Liu, Ting
    Liu, Wei
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Michelle
    Bai, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] Update results of anlotinib plus TQB2450 (PD-L1 blockade) combined with nab-paclitaxel and cisplatin as first-line treatment for advanced biliary tract cancer: A single-arm, open-label phase II clinical trial.
    Guo, Wen-Zhi
    Li, Lu-Hao
    Qiao, Shishi
    Li, Ren-Feng
    Zhang, Weijie
    He, Wei
    Su, Chang
    Pan, Jie
    Jin, Shui-Ling
    Zong, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345